Results 141 to 150 of about 786,681 (194)

Gaps and disparities in the treatment of chronic hepatitis B infection in the USA. [PDF]

Gastroenterol Rep (Oxf)
Wong RJ.
europepmc   +1 more source

Antibody responses after hepatitis B vaccination among maintenance haemodialysis patients

, 1970
Kamrun Nahar, Munira Jahan, Afzalun Nessa, S Tabassum   +3 more
openalex   +2 more sources

Investigational RNA Interference Agents for Hepatitis B. [PDF]

BioDrugs
Hui RW, Mak LY, Seto WK, Yuen MF.
europepmc   +1 more source

B-Cell Activation Gene Signature in Blood and Liver of Hepatitis B e Antigen-Positive Patients With Immune Active Chronic Hepatitis B. [PDF]

J Infect Dis
Osmani Z, Beudeker BJB, Groothuismink ZMA, de Knegt RJ, Chung RT, Aerssens J, Bollekens J, Janssen HLA, Gehring AJ, Lauer GM, Shalek AK, van de Werken HJG, Boonstra A.   +12 more
europepmc   +1 more source

Some Properties of Hepatitis B Core Antigen Isolated from Serum of Infected Humans

, 1978
A. R. Neurath, S N Huang, N. Strick
openalex   +1 more source

Induction of hepatitis B core protein aggregation targeting an unconventional binding site. [PDF]

Elife
Khayenko V, Makbul C, Schulte C, Hemmelmann N, Kachler S, Böttcher B, Maric HM.   +6 more
europepmc   +1 more source

Hepatitis B infection: Evaluation of demographics and treatment of chronic hepatitis B infection in Northern-western Tanzania. [PDF]

PLoS One
Mlewa M, Nyawale HA, Henerico S, Mangowi I, Shangali AR, Manisha AM, Kisanga F, Kidenya BR, Jaka H, Kilonzo SB, Mirambo MM, Mshana SE.   +11 more
europepmc   +1 more source

Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma. [PDF]

Exp Hematol Oncol
Hao B, Liu Y, Wang B, Wu H, Chen Y, Zhang L.   +5 more
europepmc   +1 more source

Current status of drug therapy for chronic hepatitis B. [PDF]

World J Gastroenterol
Jiang C, Zhang ZH, Li JX.
europepmc   +1 more source